epitel - Epitel Secures 125 Million Series A vernon seventeen Financing for Wearable BioUtah Epitel offers a remote EEG monitoring system that uses four wireless sensors to capture brain activity and transmit it to a cloud platform The system is designed for use in emergency rooms intensive care units and ambulatory settings and can help detect seizures and reduce healthcare costs Epitel is a Salt Lake Citybased company that develops and commercializes a platform for remote brainwave monitoring and seizure management It has raised 125 million in Series A funding to launch its FDAcleared REMI Platform which consists of wireless sensors mobile software and cloud analytics Epitel Epitel develops and sells wearable wireless EEG monitoring systems for seizure detection and other brain health applications Epitels products include REMI Remote EEG Monitoring System and REMI Vigilenz AI For Event Detection which are FDA cleared and cloudbased Epitel is a company that develops and sells wireless EEG monitoring systems for healthcare facilities and ambulatory use REMI is a system that uses disposable sensors AI technology and cloudbased software to capture and analyze brain electrical activity Epitel Secures 125 Million Series A Financing for Wearable Wireless Epitel raises 125M for wearable seizure detection system Epitel Lands a 125 Million Series A Round of Funding to Help Launch Epitel Epitel is a biotechnology research company that develops and offers wireless EEG monitoring and detection devices for seizure disorders Learn about their products noprenia awards events and mission on their LinkedIn page Epitel is a startup that develops a wireless sensor and software for monitoring seizures in patients It has raised 125 million in Series A funding and plans to expand its product pipeline for ambulatory and athome care Epitel is a digital health company that develops wireless and wearable EEG sensors and software for seizure detection It has raised 125 million in Series A financing and received FDA clearance for its first product REMI for hospital use Epitel Epitel is a digital health company developing a wearable wireless EEG monitoring platform to provide accessible affordable and reliable for seizure detection Epitel received FDA clearance for its first product known as REMI for use within hospital emergency rooms and critical care units in 2021 Epitel LinkedIn Epitel Closes 125 Million Series A Financing for Seizure Detection Epitel is a digital health company revolutionizing how brain health is monitored by combining wearable EEG technology with cloudbased data analytics and machinelearning capabilities We design and develop wireless solutions that provide longterm monitoring where you are when you need it Our initial focus is epilepsy for which we created Epitel is a digital health company that develops a platform for seizure detection using wearable wireless sensors and cloudbased software It has received FDA clearance for its first product REMI and raised 125 million for commercialization and hotel blitar further development Epitel InsideScientific
logo gopay
dexymox forte
